Diabetes Pathogenesis
Reports describe recent advances in diabetes pathogenesis research
Published in Obesity and Diabetes Week, August 22nd, 2005
Study 1: Serum concentrations of an endogenous inhibitor of nitric oxide synthase are related to level of metabolic control, not diabetes duration.
"This study was designed to investigate the effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase N-G, N-G-asymmetric dimethylarginine (ADMA) in patients and rats with diabetes, and to determine whether elevated endogenous ADMA is implicated in endothelial dysfunction or macroangiopathy in diabetes.
"Experimental diabetic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Adipose Tissue
Newly discovered endocrine functions of white adipose tissue reviewed - Heart Disease Risk Factors
Cardiac dysfunction linked to altered myocardial insulin signaling - Metabolic Syndrome
Insulin receptor activator and PPAR agonist used for metabolic syndrome - Obesity and Diabetes
Adipose tissue metabolism and CD11b expression in obesity examined - Obesity and Diabetes
C-reactive protein linked to body fat and diabetes in Asian Indians - Adipose Tissue
Rosiglitazone upregulates lipases in brown adipocytes - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
